Preemptive analgesia installation during gynecologic laparoscopy: a randomized trial

Area of Science:

• Gynecologic Surgery
• Pain Management
• Anesthesiology

Background:

• Postoperative pain is a significant concern following gynecologic laparoscopy.
• Effective pain management strategies are crucial for patient recovery and satisfaction.

Purpose of the Study:

• To assess the efficacy of intraoperative bupivacaine infusion for postoperative pain relief in gynecologic laparoscopy.
• To evaluate the impact of bupivacaine on shoulder tip pain, abdominal parietal pain, and abdominal visceral pain.

Main Methods:

• Prospective, double-blind, randomized controlled trial involving 91 women undergoing gynecologic laparoscopic surgery.
• Patients received intraperitoneal bupivacaine infusion either postoperatively (Group A), pre- and postoperatively (Group B), or placebo (Group C).
• Pain was assessed using a visual analog scale at multiple postoperative time points.

Main Results:

• Abdominal visceral pain was significantly reduced in Group B compared to placebo at 2 and 4 hours postoperatively (p < .01).
• No significant differences were observed in shoulder tip pain, abdominal parietal pain, hospital stay, or analgesic consumption.
• The analgesic effect of bupivacaine appeared to last less than 8 hours and was not dose-dependent.

Conclusions:

• Intraperitoneal bupivacaine is effective in reducing abdominal visceral pain after non-advanced gynecologic laparoscopy.
• Bupivacaine did not significantly alleviate shoulder tip pain or abdominal parietal pain.
• The analgesic duration was limited, suggesting a need for further research into optimizing bupivacaine administration for sustained pain relief.